Yoji Hakamata - Nursing Science

Author Information

Yoji Hakamata is affiliated with the Department of Basic Science at Nippon Veterinary and Life Science University, specifically within the School of Veterinary Nursing and Technology, located in Tokyo, Japan. His research interests span various aspects of veterinary and medical sciences.

Research Contributions

Yoji Hakamata has made significant contributions to the field, particularly in the areas of pulmonary arterial hypertension, hydrogen gas therapy, and the impact of dietary supplements on health. His recent research includes studies on the inhibition of neutrophil extracellular traps, organoid-based treatments for short bowel syndrome, and the effects of hydrogen gas on blood pressure. Additionally, he has explored the role of Aryl hydrocarbon receptor signaling in colitis and hypertension, and the potential therapeutic benefits of vitamin D supplementation in preventing right ventricular remodeling in pulmonary hypertension.

Aliases

Yoji Hakamata is also known by the aliases Y Hakamata and Y. Hakamata.

Publication and Citation Metrics

Metric	Value
Total Papers	138
Total Citations	2859
h-index	28

Publications:

H2 Inhibits the Formation of Neutrophil Extracellular Traps

DOI: 10.1016/j.jacbts.2021.11.005

Year: 2022

An organoid-based organ-repurposing approach to treat short bowel syndrome.

DOI: 10.1038/s41586-021-03247-2

Year: 2021

Pulmonary Arterial Hypertension Caused by AhR Signal Activation Protecting Against Colitis.

DOI: 10.1164/rccm.202009-3385LE

Year: 2020

A microsurgical technique for catheter insertion in the rat femoral artery 1

DOI: 10.1590/s0102-865020200100000004

Year: 2020

Daily inhalation of hydrogen gas has a blood pressure-lowering effect in a rat model of hypertension

DOI: 10.1038/s41598-020-77349-8

Year: 2020

Abstract 640: Indigo Naturalis, a Promising Herbal Medicine for Ulcerative Colitis, Can Induce Experimental Pulmonary Arterial Hypertension via Aryl Hydrocarbon Pathway

DOI: 10.1161/res.125.suppl_1.640

Year: 2019

Endothelial-Mesenchymal Transition Drives Expression of CD44 Variant and xCT in Pulmonary Hypertension.

DOI: 10.1165/rcmb.2018-0231OC

Year: 2019

Poor outcomes in carriers of the RNF213 variant (p.Arg4810Lys) with pulmonary arterial hypertension.

DOI: 10.1016/j.healun.2019.08.022

Year: 2019

Therapeutic impact of dietary vitamin D supplementation for preventing right ventricular remodeling and improving survival in pulmonary hypertension

DOI: 10.1371/journal.pone.0180615

Year: 2017

A new in vivo analysis model to detect sexually dimorphic rat liver cytochrome P450 gene expression dependent on growth hormone secretory patterns

DOI: 10.1538/expanim.16-0030

Year: 2016

Why Do Overlapping Appointments Occur?

How to Start Organizing a Nursing Workspace?

What Role Does Leadership Play in Patient Safety?

What is Limited Sun Exposure?

What are the Challenges of Music Therapy in Nursing?

What is the Role of Students in Accreditation?

How are Policies Developed in Nursing?

What is Blood Plasma Concentration?

What are the benefits of simulation-based training in nursing education?

How Do These Costs Impact Healthcare Facilities?

Partnered Content Networks

Relevant Topics